LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated October 24, 2013 (CVR Agreement) from listing on the NASDAQ Global Select Market on February 2, 2015, contemporaneously with their redemption. The CVRs are currently listed under the symbol CBSTZ.
Cubist is withdrawing the CVRs from listing in connection with the Failure Purchase (as such term is defined in the CVR Agreement) of all outstanding CVRs on February 2, 2015 in accordance with the terms of the CVR Agreement. On February 2, 2015, all outstanding CVRs will be purchased by Cubist and cancelled. Cubist has not arranged, nor does it intend to arrange, for the listing of the CVRs on another securities exchange or for quotation on any other quotation medium.
Help employers find you! Check out all the jobs and post your resume.
Cubist is withdrawing the CVRs from listing in connection with the Failure Purchase (as such term is defined in the CVR Agreement) of all outstanding CVRs on February 2, 2015 in accordance with the terms of the CVR Agreement. On February 2, 2015, all outstanding CVRs will be purchased by Cubist and cancelled. Cubist has not arranged, nor does it intend to arrange, for the listing of the CVRs on another securities exchange or for quotation on any other quotation medium.
Help employers find you! Check out all the jobs and post your resume.
